Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

Researchers at Stanford University in the US have developed new sensors that can be adhered to the skin for wireless monitoring of health. The sensors are designed to identify the physiological signals that the skin emanates, such as pulse. These readings will be wirelessly transmitted to a receiver clipped onto clothing. The sensor and receiver system has been named BodyNet.

The majority of women who undergo surgery for suspected ovarian cancer do not actually have the disease, but these unnecessary surgeries could soon be reduced thanks to a novel blood test developed by a Swedish research team.

A UK study has shown potential for a new blood test to diagnose human tuberculosis (TB) and identify those most at risk of developing the disease.

Researchers at Heriot-Watt University in Edinburgh, Scotland are developing smart sensors which can monitor the healing progress of a wound, eliminating the need to look underneath a bandage.

Despite advances in the renal cell carcinoma (RCC) therapy landscape, the majority of patients with RCC will eventually develop resistance to available therapies and the disease will progress through several stages, requiring further lines of treatment.

Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study. By leveraging the use of the latest techniques, such as FLASH radiotherapy and artificial intelligence (AI), the network aims to accelerate the development of advanced radiotherapy.

Breast cancer is the most frequently diagnosed cancer in women. It is estimated that 1 in 8 women will develop breast cancer in their lifetime.

Breast cancer is the most frequently diagnosed cancer in women. It is estimated that 1 in 8 women will develop breast cancer in their lifetime. Unfortunately, most women actually pursue breast cancer expression without knowing it.

Other specified feeding or eating disorder or OSFED, is a catch-all category developed for those who do not fit into the diagnostic criteria for anorexia nervosa, bulimia nervosa, or binge eating disorder. Individuals diagnosed with OSFED show symptoms similar to those specified eating disorders, but one or two key features are missing or different.

Kidney cancer care in India is well-developed and offers a comprehensive range of services for patients. We have several renowned surgeons and oncologists that specialise in the diagnosis, treatment, and management of kidney cancer.

Indswift today is a renowned name among lakhs of employees of railways, armed forces, police force & paramilitary organizations. With the help of our Institution division we are able to cater to smallest & biggest government dispensaries, hospitals and remote and rural areas in India.

What is diverticulitis and what signs and symptoms occur when you have diverticulitis? What Foods You Should Eat If You Have Diverticulitis and what you should not eat when you discovered you have diverticulitis. Described many causes in this article if you are looking for causes of diverticulitis.

Diverticulitis is a very serious medical condition. It causes inflamed pouches in the lining of your intestine. It is a very serious medical condition that causes infection or inflammation of small pouches in the lining of your intestine that is known as diverticula that develop along the walls of the intestines.